Instalab

Eosinophil Protein X Test Stool

Get an early read on allergy-driven gut inflammation that other stool tests can miss.

Should you take a EPX test?

This test is most useful if any of these apply to you.

Living With Unexplained Gut Symptoms
If diarrhea, bloating, or cramping keeps returning and standard tests look clean, this can flag allergy-driven gut inflammation.
Managing Food Allergies or Sensitivities
See whether the foods you are avoiding are truly quieting your gut, or whether hidden triggers are still inflaming your intestinal lining.
Already Diagnosed With IBD
Track whether your treatment is actually calming eosinophil-driven inflammation, not just reducing the symptoms you notice.
Parenting a Child With Eczema and Gut Issues
Infants with atopic eczema often have silent gut inflammation, and this test can help judge whether an elimination diet is working.

About Eosinophil Protein X

If you have stubborn gut symptoms that flare with certain foods or feel different from a typical infection, a standard stool inflammation test may come back reassuringly normal. That can happen because the most commonly used fecal marker tracks one type of immune cell, and it can quietly miss a different, allergy-driven pattern of inflammation that another immune cell produces.

EPX (eosinophil protein X), also called eosinophil-derived neurotoxin, is a chemical released by an allergy-related white blood cell called the eosinophil. When eosinophils are active in your intestines, they spill EPX into your stool. Measuring it gives you a window into a specific kind of gut inflammation tied to food sensitivities, certain forms of inflammatory bowel disease, and allergic conditions.

What This Test Actually Measures

Eosinophils are white blood cells that your body deploys against allergens, parasites, and certain forms of tissue injury. When they activate and rupture (a process called degranulation), they release their contents, including EPX, into the surrounding tissue. Finding EPX in your stool means eosinophils have been doing damage in your intestinal lining recently.

This is different from counting eosinophils in your blood. A blood eosinophil count tells you how many of these cells are circulating. Fecal EPX tells you what they are actually doing at the gut wall. The two numbers can disagree, which is why EPX adds information a complete blood count cannot provide on its own.

Inflammatory Bowel Disease

The strongest clinical use of fecal EPX is helping distinguish organic bowel disease from functional bowel symptoms. In adults with chronic diarrhea, a fecal EPX cutoff of 1,357 nanograms per milliliter correctly ruled out active inflammatory bowel disease (IBD, which includes Crohn's disease and ulcerative colitis) in roughly 89 out of 100 people who did not have active disease. The same cutoff caught only about 50 out of 100 people who did have active disease, so a normal result is less reassuring than a high result is informative.

When the test goes up, it tends to mean something. In that study, fecal EPX showed higher specificity and a higher positive predictive value for active IBD than fecal calprotectin, the more commonly used stool inflammation marker. In other words, a high fecal EPX was more likely to reflect real disease activity than a high calprotectin result in the same patients.

Fecal EPX also moves with treatment. In a cohort of IBD patients starting biologic therapy or corticosteroids, fecal EPX fell significantly in those who achieved clinical remission. That makes it useful not only for asking whether disease is active now, but also for asking whether a treatment is actually calming the gut.

Food Allergy and Intestinal Allergic Inflammation

In infants with atopic eczema and food allergy, fecal EPX is markedly elevated compared with healthy controls, reflecting allergic inflammation inside the gut even when symptoms are mostly on the skin. When an accurate elimination diet is started, fecal EPX drops, tracking the resolution of that intestinal inflammation. This pattern supports using fecal EPX to monitor whether an elimination diet is truly quieting the immune response in the gut, not just reducing the symptoms you notice.

Irritable Bowel Syndrome and Functional Symptoms

In irritable bowel syndrome (IBS), a condition once assumed to involve no measurable inflammation, fecal EPX can be elevated even when calprotectin and neutrophil markers are not. One study in adults with IBS found higher fecal markers reflecting intestinal epithelial cell activity and eosinophil activity, without classic inflammatory signals. If you have been told your symptoms are functional but a low-level immune process keeps simmering, fecal EPX may detect activity that other tests miss.

Reference Ranges

Fecal EPX is an emerging marker without fully standardized clinical cutpoints. The ranges below come from published research in adults with chronic diarrhea undergoing workup for IBD, measured by one specific immunoassay. They are illustrative orientation, not universal targets. Your lab will likely report different numbers and may use different units, so compare your results within the same lab over time for the most meaningful trend.

TierApproximate RangeWhat It Suggests
Below thresholdUnder 1,357 ng/mLActive inflammatory bowel disease is less likely, though not excluded
Above threshold1,357 ng/mL or higherPattern consistent with active eosinophil-driven or inflammatory bowel disease; warrants further workup

Source: Lyutakov et al., Journal of Crohn's and Colitis, 2019.

Why One Reading Is Not Enough

Eosinophil activity in the gut is not constant. It changes with active flares, dietary exposures, parasite burden, and treatment response. A single reading is a snapshot. What matters more is the direction of change when you modify something, whether that is starting a biologic, removing a food, or treating an infection.

A sensible cadence is to get a baseline when symptoms are present, retest in 4 to 12 weeks after making a change such as an elimination diet or a new prescription, and then at least annually if you are managing a chronic condition like IBD or a known food allergy. If you are healthy and simply curious, a single baseline is a reasonable starting point to revisit if symptoms develop later.

When Results Can Be Misleading

A few factors can distort a single reading. Knowing them helps you interpret an unexpected result before acting on it.

  • Circadian variation: serum and urinary EPX peak at night and early morning and trough during midday. Evidence for a similar pattern in stool is limited, but collection timing and consistency across retests is a reasonable precaution.
  • Recent or ongoing parasitic infection: parasites such as hookworm and schistosomes cause substantial eosinophil activation, and fecal EPX can fall sharply after treatment with praziquantel. If travel or exposure is recent, infection deserves ruling out.
  • Recent corticosteroid or biologic dosing: if you took a systemic corticosteroid or received a dose of an anti-eosinophil biologic shortly before testing, your result may be suppressed and underestimate your usual level.
  • Sample handling: stool samples need to be collected and shipped per the lab's instructions. Delays or temperature deviations can degrade the sample and produce unreliable numbers.

What To Do If Your Result Is Elevated

An elevated fecal EPX tells you something is irritating your gut, but not exactly what. The next step depends on the rest of your picture. If you have ongoing diarrhea, blood in your stool, weight loss, or a family history of IBD, pair the result with fecal calprotectin and consider referral to a gastroenterologist for endoscopic evaluation. If you have known food allergies, atopic disease, or eczema, pair it with a careful food and symptom diary and consider an allergist-supervised elimination approach. If you recently traveled or have exposure risk, add a stool parasite panel.

If your result is normal but you still have symptoms, do not stop there. A normal fecal EPX does not rule out everything, and other stool and blood markers can still fill in the picture.

What Moves This Biomarker

Evidence-backed interventions that affect your EPX level

Decrease
Follow an accurate elimination diet for diagnosed food allergy
If you or your child has food allergy driving gut inflammation, removing the trigger food drops fecal EPX substantially. In 38 infants with atopic eczema and food allergy, fecal EPX was markedly elevated compared with controls and fell significantly after an adequate elimination diet, tracking the resolution of intestinal allergic inflammation. This is one of the few interventions with direct evidence on stool EPX rather than blood or urine.
DietStrong Evidence
Decrease
Biologic therapy targeting eosinophils (anti-IL-5 agents such as mepolizumab or benralizumab) for eosinophilic or inflammatory bowel disease
Biologic therapies that deplete or inactivate eosinophils lower fecal EPX. In 66 IBD patients, fecal EDN (the same molecule as EPX) fell significantly in those who achieved clinical remission on biologic therapy, mirroring reductions in neutrophil markers. In severe asthma, the same class of drugs normalized serum EPX in nearly all patients, supporting a strong systemic effect on the protein. These drugs are prescribed for specific diseases, not to lower a lab number in isolation.
MedicationStrong Evidence
Decrease
Praziquantel treatment for schistosomiasis or other helminth infection
In 192 people infected with Schistosoma mansoni, treatment with praziquantel significantly reduced fecal EPX and ECP (another eosinophil granule protein), reflecting resolution of parasite-driven intestinal eosinophil activation. Reinfection caused fecal EPX to rise again, confirming that the marker tracks active parasite-related inflammation, not just past exposure.
MedicationStrong Evidence
Decrease
Corticosteroid therapy (systemic or locally acting) for active eosinophilic or inflammatory bowel disease
Corticosteroids suppress eosinophil activity and lower EPX across multiple tissue compartments. In the same 66-patient IBD cohort, fecal EDN declined in patients responding to corticosteroid therapy. Most direct evidence for corticosteroids lowering EPX comes from airway and blood measurements rather than stool, so effects on your specific fecal reading may vary.
MedicationModerate Evidence

Frequently Asked Questions

References

11 studies
  1. Lyutakov I, Nakov R, Nakov V, Vladimirov B, Asenova B, Chetirska M, Dimov a, Vatcheva-dobrevska R, Penchev PJournal of Crohn's and Colitis2019
  2. Ling Lundström M, Peterson C, Hedin CRH, Bergemalm D, Lampinen M, Magnusson MK, Keita AV, Kruse R, Lindqvist CM, Repsilber D, D'amato M, Hjortswang H, Strid H, Söderholm J, ÖHman L, Venge P, Halfvarson J, Carlson MAlimentary Pharmacology & Therapeutics2024
  3. Ling Lundström M, Peterson C, Lampinen M, Hedin C, Keita a, Kruse R, Magnusson M, Lindqvist C, Repsilber D, D'amato M, Hjortswang H, Strid H, Rönnblom a, Söderholm J, ÖHman L, Venge P, Halfvarson J, Carlson MClinical and Translational Gastroenterology2023
  4. Venge P, Castro Tejera V, Petersson CGB, Xu S, Larsson a, Simrén M, ÖHman L, Törnblom HNeurogastroenterology and Motility2024